Literature DB >> 23982649

The feasibility of delivering a duodenal-jejunal bypass liner (EndoBarrier) endoscopically with patients under conscious sedation.

Parviez Koehestanie1, Bark Betzel, Kemal Dogan, Frits Berends, Ignace Janssen, Edo Aarts, Marcel Groenen, Peter Wahab.   

Abstract

BACKGROUND: The endoscopically placed duodenal-jejunal bypass liner (DJBL) or EndoBarrier gastrointestinal liner has been designed for the treatment of type 2 diabetes mellitus and simultaneous achievement of weight loss by obese patients. This study was performed to determine the safety, efficacy, and feasibility of delivering the DJBL with the patient under conscious sedation (CS). The primary end points of the study were safety and complications. The secondary end points were delivery time (min), amount of propofol (mg) used, and the total hospital stay (h).
METHODS: This prospective study compared placement of the DJBL with the patient under propofol sedation and placement with the patient under general anesthesia (GA). The study included 56 patients, with 28 patients in each group.
RESULTS: Both groups were comparable in terms of age, gender, and body mass index. All the devices were placed successfully, and no complications occurred in either group. Comparison of the CS group with the GA group respectively showed a mean total operation time of 29 versus 56 min, a mean propofol use of 170 versus 258 mg, and a mean hospital stay of 11 versus 22 h.
CONCLUSION: Delivery of the DJBL to patients under CS is feasible, safe, and efficient in terms of time and cost. Because of possible complications during the procedure, the authors recommend placement of the DJBL with the patient under CS in proximity to the operating room.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23982649     DOI: 10.1007/s00464-013-3143-9

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  30 in total

1.  Implantation of the duodenal-jejunal bypass sleeve under conscious sedation: a case series.

Authors:  Rodrigo Montaña; Milenko Slako; Alex Escalona
Journal:  Surg Obes Relat Dis       Date:  2011-07-13       Impact factor: 4.734

2.  Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner.

Authors:  Eduardo G H de Moura; Bruno C Martins; Guilherme S Lopes; Ivan R Orso; Suzana L de Oliveira; Manoel P Galvão Neto; Marco A Santo; Paulo Sakai; Almino C Ramos; Arthur B Garrido Júnior; Marcio C Mancini; Alfredo Halpern; Ivan Cecconello
Journal:  Diabetes Technol Ther       Date:  2011-09-20       Impact factor: 6.118

Review 3.  Endoluminal and transluminal surgery: current status and future possibilities.

Authors:  A Malik; J D Mellinger; J W Hazey; B J Dunkin; B V MacFadyen
Journal:  Surg Endosc       Date:  2006-07-24       Impact factor: 4.584

4.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

Review 5.  Obesity.

Authors:  P Björntorp
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

Review 6.  Obesity and hypertension.

Authors:  N Mikhail; M S Golub; M L Tuck
Journal:  Prog Cardiovasc Dis       Date:  1999 Jul-Aug       Impact factor: 8.194

7.  Pretracheal abscess following two weeks of endotracheal intubation.

Authors:  Narayan Neupane; M Frances Schmidt; Neerja Gulati; Muhammad Perwaiz; Fadi Hammoudeh; Eneh Kennedy; Mehjabin Zahir; Danilo Enriquez; Joseph Quist
Journal:  Yale J Biol Med       Date:  2011-03

8.  First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve.

Authors:  Leonardo Rodriguez-Grunert; Manoel Passos Galvao Neto; Munir Alamo; Almino Cardoso Ramos; Percy Brante Baez; Michael Tarnoff
Journal:  Surg Obes Relat Dis       Date:  2008 Jan-Feb       Impact factor: 4.734

9.  A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery.

Authors:  Ruben Schouten; Carianne S Rijs; Nicole D Bouvy; Wim Hameeteman; Ger H Koek; Ignace M C Janssen; Jan-Willem M Greve
Journal:  Ann Surg       Date:  2010-02       Impact factor: 12.969

Review 10.  The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Authors:  J Picot; J Jones; J L Colquitt; E Gospodarevskaya; E Loveman; L Baxter; A J Clegg
Journal:  Health Technol Assess       Date:  2009-09       Impact factor: 4.014

View more
  2 in total

Review 1.  Endoscopic Accessories Used for More Advanced Endoluminal Therapeutic Procedures.

Authors:  Hyunsoo Chung
Journal:  Clin Endosc       Date:  2017-05-31

2.  A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus.

Authors:  Michael Alan Glaysher; Aruchuna Mohanaruban; Christina Gabriele Prechtl; Anthony P Goldstone; Alexander Dimitri Miras; Joanne Lord; Navpreet Chhina; Emanuela Falaschetti; Nicholas Andrew Johnson; Werd Al-Najim; Claire Smith; Jia V Li; Mayank Patel; Ahmed R Ahmed; Michael Moore; Neil Poulter; Stephen Bloom; Ara Darzi; Carel Le Roux; James P Byrne; Julian P Teare
Journal:  BMJ Open       Date:  2017-11-15       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.